SCHEMBL25515741

SCHEMBL25515741

CCCCCCC(=O)c1ccc2c(c1)c1cc(C(=O)c3ccc(OC(=O)c4cccs4)cc3)ccc1n2CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.45
PLA2G1B P04054 2/20 0.45
ATG4B Q9Y4P1 2/20 0.45
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44
CNR2 P34972 2/20 0.44
TSHR P16473 3/20 0.40
HPGD P15428 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 3/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 1/20 0.39
P4HB P07237 1/20 0.38
PLA2G2A P14555 2/20 0.37
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23802091 1.00 KMT2A (0.45) KMT2APLA2G1BATG4BMAPTL3MBTL1
SCHEMBL25515739 0.88 KMT2A (0.41) KMT2APLA2G1BATG4BMAPTL3MBTL1
SCHEMBL23801805 0.85 KMT2A (0.41) KMT2APLA2G1BATG4BMAPTL3MBTL1
SCHEMBL25515494 0.84 CNR2 (0.48) KMT2ACNR2NPC1RAB9APLA2G2A
SCHEMBL25515534 0.83 CNR2 (0.49) KMT2AHRH2HRH1CNR2HPGD
SCHEMBL23802413 0.81 CNR2 (0.46) HRH2HRH1CNR2PLA2G2ATUBB4A
SCHEMBL23802405 0.81 CNR2 (0.46) HRH2HRH1CNR2PLA2G2ATUBB4A
SCHEMBL25515644 0.81 CNR2 (0.46) HRH2HRH1CNR2PLA2G2ATUBB4A
SCHEMBL25515622 0.81 CNR2 (0.45) L3MBTL1HRH2HRH1CNR2PLA2G2A
SCHEMBL3184975 0.80 CNR2 (0.65) MAPTL3MBTL1CNR2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 KMT2A 3437/4885PLA2G1B 3031/4885ATG4B 2362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.